Live Breaking News & Updates on Late Breaking Oral Presentation

Stay updated with breaking news from Late breaking oral presentation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021

UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Bruxelles Capitale , Emmanuel Caeymaex , Eimear Obrien , Isabelle Ghellynck , J Clin Dermatol , Antje Witte , Laurent Schots , J Clin Pharmacol , American Academy Of Dermatology Virtual Meeting , Immunology Solutions , Brand Communications , World Health Organization , International Federation Of Psoriasis Associations , Corporate Communications , National Psoriasis Foundation , Source Ucb Inc , American Academy , Dermatology Virtual Meeting Experience , Executive Vice President , Psoriasis Symptoms , Impacts Measure , Late Breaking Oral Presentation , Euronext Brussels , Arthritis Res , Psoriatic Arthritis ,

UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021

UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Bruxelles Capitale , Emmanuel Caeymaex , Eimear Obrien , Isabelle Ghellynck , J Clin Dermatol , Antje Witte , Laurent Schots , J Clin Pharmacol , American Academy Of Dermatology Virtual Meeting , Immunology Solutions , Brand Communications , World Health Organization , International Federation Of Psoriasis Associations , Corporate Communications , National Psoriasis Foundation , Source Ucb Inc , American Academy , Dermatology Virtual Meeting Experience , Executive Vice President , Psoriasis Symptoms , Impacts Measure , Late Breaking Oral Presentation , Euronext Brussels , Arthritis Res , Psoriatic Arthritis ,

Arcutis Biotherapeutics to Present New Roflumilast Data at The American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX)

Share:
WESTLAKE VILLAGE, Calif., April 19, 2021 (GLOBE NEWSWIRE) Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, will present new data from three studies evaluating the safety, efficacy, and tolerability of its once-daily, topical roflumilast cream and foam at the American Academy of Dermatology Virtual Meeting Experience (VMX) April 23 - 25, 2021.
Patients suffering from plaque psoriasis, scalp psoriasis, and seborrheic dermatitis have significant unmet needs given the lack of efficacious, safe, tolerable topical options for long-term use, said Patrick Burnett, M.D., Ph.D., FAAD, Chief Medical Officer, Arcutis. We are pleased to share these new data that further reinforce the potential of roflumilast cream and foam in various inflammatory skin diseases. If approved by the FDA, o ....

United States , Patrick Burnett , Heather Rowe Armstrong , Kim Papp , Drug Administration , Exchange Commission , American Academy Of Dermatology Virtual Meeting Experience , Arcutis Biotherapeutics Inc , American Academy , Dermatology Virtual Meeting Experience , Chief Medical Officer , Late Breaking Oral Presentation , Vehicle Controlled Phase , Presentation Plus Recording , Roflumilast Foam , Seborrheic Dermatitis , Mitch Response , Roflumilast Cream , Disease Severity , Patient Reported Outcomes , Chronic Plaque Psoriasis , Measuring Disease Severity , Mild To Moderate Plaque Psoriasis , Topical Roflumilast Cream , Media Contact , ஒன்றுபட்டது மாநிலங்களில் ,